ITC judge deems main patent relating to NobelActive® invalid

Neodent continues selling its DriveCM™ line of dental implants

Andover, MA, October 29, 2015 -- The Administrative Law Judge at the International Trade Commission who has presided over the patent dispute brought by Nobel Biocare against Instradent and Neodent has determined that Nobel Biocare's main patent relating to key features of its NobelActive® design is invalid. In his Initial Determination the judge largely followed Neodent's arguments.

“The outcome of this case does not change anything for our customers and we are pleased that we can continue to offer both our DriveCM™ and DriveCM Acqua™ as attractively-priced high-quality alternatives to NobelActive®”, commented Bill Benjaminsen, General Manager of Instradent USA.

The validity of Nobel Biocare’s patent relating to grooves in the thread of the NobelActive implant is still under review, but these do not feature in any of Neodent’s current products sold in or outside the US.

About Instradent

With a dedicated team at its headquarters in Basel, Switzerland, Instradent was established in 2014 as a business platform to drive and manage the distribution and internationalization of specific brands for tooth replacement solutions. These leading brands – which include Neodent, Medentika and etkon, offer high-quality, attractively-priced products, which are popular in domestic and regional markets. Our goal is to make them available to dental professionals internationally through the growing Instradent network. Instradent is a lean organization, set up to deliver superior quality at highly competitive prices and maximum customer convenience.

Instradent. Bright choice. Bright smiles.

Instradent USA, Inc.
60 Minuteman Road
Andover, MA 01810
Phone 855-412-8883



Contact: Bill Benjaminsen +1 (978) 269-6366

Disclaimer: This release contains ‘forward-looking statements’, which reflect the current views of management and are subject to risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described here. Instradent is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in it.

NobelActive® is a registered trademark of the Nobel Biocare group.